Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-30 Sale |
2023-02-01 4:17 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
924 | $11.78 | $10,884 | 111,398 (Direct) |
View |
| 2023-01-30 Sale |
2023-02-01 4:16 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
848 | $11.78 | $9,989 | 30,350 (Direct) |
View |
| 2023-01-30 Sale |
2023-02-01 4:15 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,412 | $11.78 | $16,633 | 61,490 (Direct) |
View |
| 2022-10-31 Sale |
2022-11-01 7:35 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
739 | $12.88 | $9,519 | 112,322 (Direct) |
View |
| 2022-10-31 Sale |
2022-11-01 7:34 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
699 | $12.88 | $9,003 | 31,198 (Direct) |
View |
| 2022-10-31 Sale |
2022-11-01 7:33 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,165 | $12.88 | $15,006 | 62,902 (Direct) |
View |
| 2022-10-31 Sale |
2022-11-01 7:32 pm |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
350 | $12.88 | $4,508 | 15,908 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-02 5:50 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
712 | $15.67 | $11,157 | 31,552 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-02 5:48 pm |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
356 | $15.67 | $5,579 | 14,706 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-02 5:46 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
752 | $15.67 | $11,784 | 113,061 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-02 5:45 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,186 | $15.67 | $18,585 | 64,067 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 7:05 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,098 | $11.75 | $12,902 | 65,253 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 7:04 pm |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
330 | $11.75 | $3,878 | 15,062 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 7:03 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
697 | $11.75 | $8,190 | 45,480 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 7:03 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
660 | $11.75 | $7,755 | 32,264 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-11 4:10 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $27.14 | $32,568 | 101,352 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-04 4:19 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,828 | $28.96 | $52,939 | 163,568 (Direct) |
View |
| 2021-12-10 Sale |
2021-12-13 4:47 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $29.04 | $34,848 | 102,552 (Direct) |
View |
| 2021-12-01 Sale |
2021-12-02 5:43 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $29.13 | $11,652 | 82,063 (Direct) |
View |
| 2021-11-10 Sale |
2021-11-12 5:15 pm |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $32.38 | $38,856 | 103,752 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-02 5:28 pm |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $33.24 | $13,296 | 82,463 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-30 Exercise |
2023-02-01 4:17 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,886 | $0 | 111,398 (Direct) |
View |
| 2023-01-30 Exercise |
2023-02-01 4:16 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,924 | $0 | 30,350 (Direct) |
View |
| 2023-01-30 Exercise |
2023-02-01 4:15 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
3,207 | $0 | 61,490 (Direct) |
View |
| 2022-10-30 Exercise |
2022-11-01 7:35 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,886 | $0 | 112,322 (Direct) |
View |
| 2022-10-30 Exercise |
2022-11-01 7:34 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,924 | $0 | 31,198 (Direct) |
View |
| 2022-10-30 Exercise |
2022-11-01 7:33 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
3,207 | $0 | 62,902 (Direct) |
View |
| 2022-10-30 Exercise |
2022-11-01 7:32 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
962 | $0 | 15,908 (Direct) |
View |
| 2022-09-12 Option Award |
2022-09-14 4:25 pm |
N/A 2032-09-11 |
Nurix Therapeutics Inc. | NRIX | Saltzman Edward C Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-08-09 Option Award |
2022-08-10 4:19 pm |
N/A 2032-08-08 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
40,199 | $0 | 40,199 (Direct) |
View |
| 2022-08-09 Option Award |
2022-08-10 4:18 pm |
N/A 2032-08-08 |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
110,375 | $0 | 110,375 (Direct) |
View |
| 2022-08-09 Option Award |
2022-08-10 4:17 pm |
N/A 2032-08-08 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-08-09 Option Award |
2022-08-10 4:16 pm |
N/A 2032-08-08 |
Nurix Therapeutics Inc. | NRIX | SANDS ARTHUR T President, CEO |
400,000 | $0 | 400,000 (Direct) |
View |
| 2022-08-09 Option Award |
2022-08-10 4:15 pm |
N/A 2032-08-08 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
60,298 | $0 | 60,298 (Direct) |
View |
| 2022-07-30 Exercise |
2022-08-02 5:50 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,924 | $0 | 31,552 (Direct) |
View |
| 2022-07-30 Exercise |
2022-08-02 5:48 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
962 | $0 | 14,706 (Direct) |
View |
| 2022-07-30 Exercise |
2022-08-02 5:46 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,886 | $0 | 113,061 (Direct) |
View |
| 2022-07-30 Exercise |
2022-08-02 5:45 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
3,207 | $0 | 64,067 (Direct) |
View |
| 2022-05-31 Exercise |
2022-06-01 4:57 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
68,333 | $0.84 | 70,522 (Direct) |
View |
| 2022-05-31 Exercise |
2022-06-01 4:57 pm |
N/A 2026-04-26 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
68,333 | $0 | 70,522 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 5:44 pm |
N/A 2032-05-04 |
Nurix Therapeutics Inc. | NRIX | Silva Paul M Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 5:43 pm |
N/A 2032-05-04 |
Nurix Therapeutics Inc. | NRIX | SIEGALL CLAY B Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 5:41 pm |
N/A 2032-05-04 |
Nurix Therapeutics Inc. | NRIX | Reinsdorf Judith A Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 5:40 pm |
N/A 2032-05-04 |
Nurix Therapeutics Inc. | NRIX | Lacey David L. Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 5:23 pm |
N/A 2032-05-04 |
Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 5:22 pm |
N/A 2032-05-04 |
Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-03 7:05 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
3,206 | $0 | 65,253 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-03 7:04 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
962 | $0 | 15,062 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-03 7:03 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,886 | $0 | 45,480 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-03 7:03 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,924 | $0 | 32,264 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-21 4:25 pm |
N/A 2032-01-19 |
Nurix Therapeutics Inc. | NRIX | SANDS ARTHUR T President, CEO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:17 pm |
N/A 2032-01-18 |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
50,023 | $0 | 50,023 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:16 pm |
N/A 2032-01-18 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
150,071 | $0 | 150,071 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:15 pm |
N/A 2032-01-18 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
100,047 | $0 | 100,047 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:14 pm |
N/A 2032-01-18 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
166,746 | $0 | 166,746 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-11 4:10 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $1.86 | 101,352 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-11 4:10 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $0 | 101,352 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 4:19 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,428 | $9.57 | 163,568 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 4:19 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $7.26 | 163,568 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 4:19 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
1,828 | $0 | 163,568 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-13 4:47 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $1.86 | 102,552 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-13 4:47 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $0 | 102,552 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-02 5:43 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $7.26 | 82,063 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-02 5:43 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $0 | 82,063 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-12 5:15 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $1.86 | 103,752 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-12 5:15 pm |
N/A 2029-09-30 |
Nurix Therapeutics Inc. | NRIX | Ring Christine General Counsel |
1,200 | $0 | 103,752 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-02 5:28 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $7.26 | 82,463 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-02 5:28 pm |
N/A 2030-02-26 |
Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer |
400 | $0 | 82,463 (Direct) |
View |